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Extracranial-intracranial bypass: Resurrection of a
nearly extinct operation
Ryan M. Gobble, MD,a Han Hoang, MD,a Jafar Jafar, MD,b and Mark Adelman, MD,c New York, NY
Background: Giant intracranial artery aneurysms (GIAAs) are often not amenable to neurosurgical clipping or endovas-
cular coiling. Extracranial-intracranial (EC-IC) bypass, a procedure that has been essentially abandoned for the treatment
of intracranial ischemic disease, followed by parent vessel occlusion, is often successful in treating these aneurysms.
Vascular surgeons should be familiar with this operation, especially in centers with neurosurgical capability.
Methods: A retrospective review of patients treated from 1990 to 2010 at New York University Medical Center was
performed. Office and hospital records of all patients identified were reviewed with attention to the age and sex of the
patient, presenting symptoms, preoperative testing, procedure performed, type of bypass conduit, graft patency,
intraoperative and postoperative complications, length of follow-up, and overall outcome. EC-IC bypass was performed
using a graft of great saphenous vein (GSV) or radial artery (RA). The vascular surgeon harvested the vascular conduit,
tunneled the graft, and performed the extracranial anastomosis, and the intracranial anastomosis was performed by the
neurosurgeon.
Results: A total of 36 patients (14 men, 22 women) underwent 37 EC-IC bypasses with 34 GSV and three RA grafts. The
median age was 57 years (interquartile range, 49-66 years), and the median follow-up was 53 months (interquartile
range, 29-77 months). Aneurysm location was the internal carotid artery in 30 patients, the basilar artery in three, and
the middle cerebral artery in four. All 37 aneurysms were excluded from the cerebral circulation, with 33 grafts remaining
patent at follow-up, as determined by serial cerebral or magnetic resonance angiogram. At follow-up, 33 of 34 of the GSV
grafts (88%) and three of three (100%) of the RA grafts were patent. There were two deaths (5.6%), despite patent grafts.
Postoperative graft occlusion led to homonymous hemianopsia in one patient and temporary hemiparesis in another
(5.6%). Graft occlusions were asymptomatic in two patients.
Conclusions: EC-IC bypass is a safe and effective treatment for GIAAs, with acceptable rates of morbidity (5.6%),
mortality (5.6%), and graft patency (89.2%). We suggest that the technique described in this report should be routinely
used for treatment of GIAAs in centers where neurosurgery and vascular surgery services are available and should be
considered a standard procedure in the armamentarium of the vascular surgeon. (J Vasc Surg 2012;56:1303-7.)
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cVascular surgeons have used extra-anatomic bypass for
years in the treatment of extracranial aneurysmal and occlu-
sive arterial diseases, with excellent results.1-3 The treat-
ment of intracranial arterial disease is usually deferred to
neurosurgeons and neurointerventionalists4-6; however,
vascular surgeons have historically treated certain intracra-
nial arterial diseases, including high cervical carotid occlu-
sions and giant intracranial artery aneurysms (GIAAs), as
part of a multidisciplinary approach.7-9 The role of the
vascular surgeon in performing extracranial-intracranial
(EC-IC) bypass usually includes harvesting the vascular
conduit, tunneling the graft, and performing the extracra-
nial anastomosis, and the neurosurgeon performs the intra-
cranial anastomosis. In our institution, we have used this
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The first EC-IC bypass was reported by Yasargil10 in
969, when he performed a bypass from the superficial
emporal artery (STA) to the middle cerebral artery (MCA)
or the treatment of a complex intracranial aneurysm. The
rocedure quickly gained favor in treating not only aneu-
ysmal disease but also cerebrovascular disease that was not
menable to carotid endarterectomy.11,12 Initial studies
ere promising, but in 1985, the randomized multicenter
C-IC Bypass Study failed to demonstrate a benefit of
TA-MCA bypass vs the best medical therapy in the treat-
ent of symptomatic atherosclerotic disease of the internal
arotid artery (ICA), and its use sharply declined thereaf-
er.13 Although not commonly used to treat intracranial
therosclerotic disease, EC-IC bypass is still routinely per-
ormed in the treatment of GIAAs.8,9,14 Vascular surgeons
hould be familiar with this operation, especially in centers
ith neurosurgical capability.
GIAAs are intracranial aneurysms with a diameter
2.5 cm.15 GIAAs include the saccular type, characterized
y a relatively small neck, and the fusiform type, which are
redominantly of atherosclerotic origin. The presence of a
arge neck, calcification, and atheroma formation within
IAAs all prevent safe surgical clipping or endovascular
oiling, the current standards of care in the treatment of
ntracranial aneurysmal disease. Although accounting for
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November 20121304 Gobble et alonly 5% of all intracranial aneurysms, the natural history
and prognosis of GIAAs is dismal.16 Natural history studies
have demonstrated 50% risk of rupture and mortality
rates of 68% to 100% at 2 years for untreated GIAAs.15,17
We believe EC-IC bypass with parent vessel occlusion is the
best surgical alternative, with dramatically improved mor-
tality rates (3%-10%).8,9
There are two options when performing EC-IC bypass.
The first involves a direct anastomosis from the STA to an
intracranial artery (STA-IC), and the second requires the
use of a conduit, either great saphenous vein (GSV) or
radial artery (RA), to bypass from the common carotid
artery (CCA) or external carotid artery (ECA) to an intra-
cranial artery (CCA-IC or ECA-IC).7,9-11,18-20 The
STA-IC bypass is known as a low-flow bypass due to the
smaller diameter of the STA andmay not be adequate when
performing a bypass to a high-flow vessel such as the
horizontal segment (M1) of the MCA or the intracranial
ICA.8,14,21 In 1971, the first CCA-IC bypass was described
using GSV as the conduit,22 and the safety and effectiveness
of this high-flow bypass was confirmed in many different
studies.11,12,18,23-25 Flow rates are higher with GSV than
with RA, which may not be advantageous when inserting
into branches of theMCA that are2mmbecause this may
cause a flow disturbance.16
EC-IC bypass using GSV or RA is a technically chal-
lenging procedure that requires vascular and neurosurgical
expertise. In our previously published series,9 we presented
the surgical technique and safety profile in 29 patients with
GIAAs who were successfully treated with EC-IC bypass,
followed by immediate parent vessel occlusion. Our current
series is a continuation of the previous study and now
includes 36 patients with GIAAs who were treated with
EC-IC bypass, followed by immediate parent vessel occlu-
sion. All EC-IC bypasses were performed by the same
neurosurgeon (J.J.) and vascular surgeon (M.A.). Despite
the advances in endovascular and neurointerventional de-
vices (eg, the pipeline embolization device) and techniques,
some patients still require EC-IC bypass.26 This report
summarizes the indications for surgery, imaging evalua-
tion, operative technique, and outcomes in patients who
underwent EC-IC bypass with a specific focus toward the
role of the vascular surgeon.
METHODS
A retrospective review of patients treated from 1990 to
2010 at New York University Medical Center was per-
formed after obtaining Institutional Review Board ap-
proval. We identified 36 patients, and their office and
hospital records were reviewed with attention to age and
sex, presenting symptoms, preoperative testing, procedure
performed, type of bypass conduit, graft patency, intraop-
erative and postoperative complications, length of follow-
up, and overall outcome.
Treatment algorithm. All 36 patients underwent
magnetic resonance imaging or computed tomography
scanning, or both, of the brain and cerebral angiography in
conjunction with occlusion xenon blood flow tomography hr balloon test occlusion. The indication for bypass in 33
atients was failure of xenon blood flow tomography, de-
ned as cerebral blood flow 30 mL/100g/min, or of
alloon test occlusion, defined as development of a neuro-
ogic deficit during a 20-minute parent vessel occlusion. In
he remaining three patients (four aneurysms), the indica-
ions for bypass included a giant aneurysm of the contralat-
ral cavernous carotid artery eroding into the sphenoid
inus, progressive hemiparesis secondary to hemodynamic
nsufficiency from a previously sacrificed ipsilateral CCA,
nd a giant vertebrobasilar aneurysm without collateral
irculation from the anterior system.
Surgical technique. For high-flow bypass, a long seg-
ent of GSV or RA was used as the vascular conduit with
he technique depicted in the Fig. The GSV was harvested
etween the ankle and the knee and marked with a sterile
en to prevent twisting during subsequent tunneling. All
ein bypasses were reversed, thus eliminating the need to
emove valves with the valvulotome, which may cause
ndothelial damage. The disadvantage of this technique is
hat it may be difficult to obtain equivalent donor and graft
umen sizes. This was overcome by choosing a segment of
ein that was relatively uniform in diameter and of an
ppropriate size match for the intracranial vessel. Any ve-
ous side branches were ligated with 5-0 silk ties. It has
een published that GSV patches are prone to aneurysmal
egeneration in the setting of carotid endarterectomy27;
ig. Surgical technique for extracranial-intracranial bypass using
reat saphenous vein (GSV) or radial artery grafts. Reproduced
ith permission from Jafar et al.9owever, we are unaware of any reports of aneurysmal
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Volume 56, Number 5 Gobble et al 1305generation of GSV grafts used as a vascular conduit in
EC-IC bypass.
The RAwas dissected between the elbow andwrist, and
all side branches were ligated, as with the GSV. One advan-
tage of using RA is that there is a uniform diameter
throughout the length of the conduit. In the later portion
of our experience, we transitioned to using RA when feasi-
ble because long-term studies in coronary artery bypass
grafting have demonstrated superior patency compared
with GSV.28
The vascular conduit was kept in situ until the proximal
and distal anastomotic sites were prepared. Next, the CCA,
ICA, and ECA were exposed through a cervical incision
over the anterior aspect of the sternocleidomastoid muscle.
A pterional craniotomy was performed with dissection of
the sylvian fissure. A passage was created by removing the
posterior portion of the zygoma using a rotating burr to
allow tunneling of the graft in the preauricular position.
The tunnel is created from the apex of the cervical incision
to the zygoma, with care taken to avoid an acute angulation
of the conduit as it passes posterior to the parotid gland. At
this point, the graft was harvested and tunneled from the
cervical to the cranial incision using a large vascular trocar. The
patient was given heparin (0.5 milligrams per kilogram) to
maintain an activated clotting time of two times control.
Dexamethasone (10 mg) and barbiturates were administered
until burst suppression was obtained on electroencephalogra-
phy.
The distal anastomosis was performed first, end to side
with 8-0 or 9-0 monofilament nylon in a running fashion,
to minimize temporary occlusion time and to allowmaneu-
verability to perform the anastomosis with 360° visibility.
To estimate the length of the conduit that would be
needed, the graft was distended with heparinized saline and
the excess trimmed using Potts scissors. Finally, the proxi-
mal anastomosis was performed. Whenever possible, to
preserve distal collaterals, the proximal anastomosis was
performed end to side to the ECA using 7-0 monofilament
nylon sutures in a running fashion. If anastomosis to the
ECA was not possible, secondary to early branching or
inappropriate graft angulation, an end-to-side anastomosis
to the CCA was performed.
Before blood flowwas restored to the brain, a 25-gauge
needle was inserted into the hood of the distal anastomosis
with initiation of blood flow proximally. The distal end of
the conduit was clamped, which allowed air to vent through
the needle, thus preventing air embolism to the brain. The
distal clamp was removed and a hemostatic agent placed over
the 25-gauge needle hole.
During the last 13 years, we have performed intraoper-
ative angiography after proximal native ICA clamping
(eliminating competitive flow) to demonstrate graft pa-
tency and to evaluate anastomotic sites. After completion
angiography, the proximal ICA clamp is removed, allowing
for the return of competitive flow. Finally, the parent vessel
was proximally ligated and anticoagulation reversed with
protamine. Although the parent vessel was not ligated
distally, all of the aneurysm still thrombosed. wAll patients received aspirin (325 mg) in the recovery
oom and daily thereafter. Postoperatively, magnetic reso-
ance angiography was used to evaluate the bypass, and
hen there were questions, a digital subtraction angiogra-
hy was performed.
ESULTS
A total of 36 patients (14 men, 22 women) underwent
7 EC-IC bypasses using 34 GSV grafts and three RA
rafts. The median age was 57 years (interquartile range,
9-66 years), and the median follow-up time was 53
onths (interquartile range, 27-77 months). Aneurysm
ocation was the ICA in 30 patients, the basilar artery in
hree, and the MCA in four (Table I). All 37 aneurysms
ere excluded from the cerebral circulation, with 33 grafts
emaining patent at follow-up, as determined by follow-up
erial cerebral or magnetic resonance angiography. At fol-
ow-up, 30 of 34 GSV grafts (88%) and all three RA grafts
100%) were patent (Table II).
Four graft occlusions (10.8%) occurred, all of which
able I. Patient demographics and clinical findings
ariable No. or median (IQR)
atients 36
Male 14
Female 22
neurysms 37
ge, years 57 (49-66)
neurysm location
Internal carotid artery 30
Paraclinoid 13
Cavernous sinus 10
Posterior communicating artery 7
Middle cerebral artery 4
Basilar artery 3
QR, Interquartile range.
able II. Surgical outcomes and complications
utcome No.
ocation of proximal anastomosis
External carotid artery 31
Common carotid artery 6
ocation of distal anastomosis
Middle cerebral artery 30
M1 3
M2 26
M3 1
Internal carotid artery 3
Superior cerebral artery 2
Posterior cerebral artery 2
raft patency
Patent 33
Not patent 4
omplications
Hemianopsia 1
Transient hemiparesis 1
eath 2ere in the GSV group. One graft occlusion occurred in a
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November 20121306 Gobble et alpatient who underwent two-stage bilateral EC-IC bypasses
for a bilateral giant cavernous aneurysm. During the second
bypass procedure, a cranial pin was placed close to the graft,
which stretched the skin and compressed the bypass, causing
the graft to occlude. Nevertheless, collateral flow was suffi-
cient and the patient remained asymptomatic. The other three
graft occlusions were secondary to poor distal runoff. In these
patients, the completion angiogram at the end of the case
demonstrated sluggish flow, despite proximal cross-clamp of
the native ICA,without evidence of stenosis or technical error.
We found that all bypass grafts that stayed patent for10
minutes had very good long-term patency. Proximal parent
artery occlusion was sufficient to completely thrombose most
aneurysms. The two aneurysms that did not immediately
thrombose did so on 3-month follow-up angiography. These
aneurysms did not thrombose immediately because there was
back flow from the graft into the aneurysm.
Morbidity andmortality. Two deaths (5.6%) occurred
in this series. One death was secondary to a subarachnoid
hemorrhage in a patient who initially presented with a stroke
and was found to have a giant basilar artery aneurysm. The
patient underwent ECA-posterior cerebral artery bypass
with GSV, followed by bilateral vertebral artery coil embo-
lization. The bypass was patent postoperatively, but the
patient developed locked-in syndrome and eventually died.
The second death occurred in a patient who underwent
ECA-MCA bypass, with a prolonged temporary occlusion
time of 60 minutes for the distal bypass vs the average
temporary occlusion time of 20 minutes. The graft was
patent postoperatively, but the patient developed a large
left hemispheric cerebral infarction and died.
Postoperative graft occlusion led to homonymous
hemianopsia in one patient and temporary hemiparesis in
another (5.6%). Graft occlusions were asymptomatic in two
patients. In all remaining patients, there was no change in
neurologic status or clinical status after EC-IC bypass, as
assessed by the senior neurosurgeon (J.J.).
DISCUSSION
Endovascular treatment of intracranial aneurysmal dis-
ease has progressed significantly in recent years and is the
preferred treatment method at most centers, with surgical
clipping reserved for patients in whom endovascular treat-
ment fails or is not technically feasible.4,29,30 There remains
a subset of patients with intracranial aneurysms (ie, GIAAs)
for whom endovascular treatment options are not yet de-
veloped and in whom surgical clipping is not only techni-
cally difficult but is also associated with a high percentage of
morbidity and mortality.31 GIAAs have always posed a
therapeutic challenge because neither endovascular coiling
nor surgical clipping is an option and endovascular stenting
often leads to recanalization and treatment failure.32,33
EC-IC bypass is an attractive method for treating GIAAs
because the aneurysm can be completely isolated from the
cerebral circulation via parent vessel occlusion while still
maintaining high-velocity blood flow, especially if GSV or
RA is used as the conduit. cFurthermore, EC-IC bypass has been demonstrated to be
relatively safe procedure, with acceptable morbidity and
ortality rates.8,14,19,34 Our data demonstrate that EC-IC
ypass is a safe and effective treatment forGIAAs, with accept-
ble rates of morbidity (5.6%), mortality (5.6%), and graft
atency (89.2%).We suggest that for treatment of GIAAs, the
echnique described in this report should be routinely used in
enters where neurosurgery and vascular surgery services are
vailable and shouldbe considered a standardprocedure in the
rmamentarium of the vascular surgeon.
Given the excellent safety profile of EC-IC bypass, it
as been suggested that the use of this technique should be
e-examined for the treatment of cerebral atherosclerotic
ascular disease.35 The determination that EC-IC bypass
as inferior to aspirin came from one randomized study in
985.13 The studied bypass was the STA-MCA bypass,
hich is a low-flow bypass and does not provide sufficient
ow to large intracranial arterial branches (eg, ICA, MCA,
1, or M2).8,14,21 There has been hope that with our new
nderstanding of cerebral blood flow requirement, that
C-IC bypass may benefit patients with intracranial cere-
ral atherosclerotic vascular disease, especially in the subset
f patients with impaired cerebral hemodynamics.
A 2010 Cochrane Database review by Fluri et al35
ound that EC-IC bypass was neither superior nor inferior
o medical therapy alone in a review of 2591 patients in 21
rials, including two randomized controlled trials. Most of
he studies in the review included patients in whom no
tratification was performed to separate patients with em-
olic stroke and sufficient intracranial hemodynamics from
hose patients with ongoing hemodynamic compromise.
The Japanese EC-IC Bypass Trial, a randomized trial of
atients with severe hemispheric hemodynamic failure
aused by cerebral artery occlusive disease, was performed
o address this issue; however, this study failed to demon-
trate a clinical benefit in the primary outcomes of “death
rom all causes” and “any stroke.”36
The Carotid Occlusion Surgery Study (COSS) was
erformed to determine if EC-IC bypass added to best
edical therapy would reduce the incidence of ipsilateral
schemic stroke in patients with recently symptomatic ath-
rosclerotic ICA occlusion.37 The COSS trial was a parallel-
roup, randomized, open-label, blinded-adjudication clin-
cal treatment trial conducted from 2002 to 2010 in which
95 patients with angiographically confirmed atheroscle-
otic ICA occlusion were randomized to receive surgery
97 patients) or no surgery (98 patients). For the surgical
roup, EC-IC bypass was performed using the STA to an
CA cortical branch. The primary end points of the study
ere “all stroke and death” and “ipsilateral ischemic
troke.” The trial was terminated early for futility because
he 2-year rates for the primary end points were 21% in the
urgical group and 22.7% for the nonsurgical group (P 
78). The 30-day ipsilateral ischemic stroke rate was 14.4%
or the surgical group and 2% in the nonsurgical group.
raft patency was 98% at 30 days and 96% at the last
ollow-up (median follow-up, 723 days). The authors con-
luded that despite excellent graft patency and improve-
11
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 5 Gobble et al 1307ment in cerebral hemodynamics, that EC-IC bypass pro-
vided no additional benefit compared with medical therapy
for preventing recurrent strokes.
CONCLUSIONS
Current literature reaffirms there is no role for EC-IC
bypass in the treatment of intracranial ischemic disease.
However, despite the advent of new endovascular tech-
niques, EC-IC bypass must remain in the armamentarium
of both vascular and neurosurgeons for the treatment of
selective GIAAs.
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